Skip to main content
. 2024 Apr 20;16(8):1228. doi: 10.3390/nu16081228

Table 2.

Gastrointestinal (GI) disorders by time according to study group.

Gluten Group (n = 17) Placebo Group (n = 27) ∆Intergroup Analysis
GI Disorders Basal Final p Basal Final p
 Abdominal pain 2 (1–2) 1 (0–1) 0.013 1 (0.5–2) 0 (0–1) 0.001 ns
 Bloating 1 (0–2) 1 (0–1) 0.033 2 (1–3) 1 (0–2) 0.000 ns
 Flatulence 1 (1–2) 1 (0–1) 0.008 2 (2–3) 1 (0–2) 0.001 ns
 Diarrhea 1 (0–1) 0 (0–0) 0.008 0 (0–2) 0 (0–0) 0.004 ns
 Stomach sounds 1 (0–2) 0 (0–1) 0.031 2 (1–2) 0 (0–1) 0.000 ns
 Reduced consistency 1 (1–2) 0 (0–1) 0.003 1 (0–2) 0 (0–0) 0.001 ns
 Constipation 0 (0–1) 1 (0–1) 0.305 0 (0–1.5) 0 (0–1) 0.177 ns
 Urge to defecate 1 (0–2) 0 (0–1) 0.031 1 (0–2.5) 0 (0–1) 0.056 ns
 Incomplete evacuation 1 (0–2) 1 (0–2) 0.886 1 (0.5–2) 1 (0–1) 0.033 ns
 Nausea 1 (0–2) 0 (0–0) 0.021 0 (0–0) 0 (0–0) 0.125 ns
 Burning 0 (0–1) 0 (0–1) 0.480 0 (0–1) 0 (0–1) 0.109 ns
 Belching 1 (0–2) 0 (0–1) 0.021 1 (0–1) 0 (0–1) 0.388 ns
 Acid regurgitation 0 (0–1) 0 (0–0) 0.375 0 (0–0.5) 0 (0–0.5) 1 ns
 Epigastric pain 0 (0–2) 0 (0–0) 0.068 0 (0–1) 0 (0–0) 0.017 ns
 Depositions 3.24 ± 2.02 2.76 ± 1.79 0.290 3 (2–6) 3 (1–4.5) 0.454 ns
 Bristol stool scale 4.24 ± 1.09 3.29 ± 1.53 0.016 4 (4–5) 4 (2.5–4) 0.047 ns

All bold show significant data. ns: not significant.